CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
-2.22%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
+$5.91M
(+0.55%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
36.46%
Holding
509
New
13
Increased
172
Reduced
270
Closed
23
Top Buys
| 1 |
Apple
AAPL
|
$12.2M |
| 2 |
Amazon
AMZN
|
$8.41M |
| 3 |
Microsoft
MSFT
|
$6.53M |
| 4 |
Analog Devices
ADI
|
$4.63M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$3.68M |
Top Sells
| 1 |
iShares Silver Trust
SLV
|
$7.9M |
| 2 |
ProShares Ultra Gold
UGL
|
$7.89M |
| 3 |
Arista Networks
ANET
|
$6.7M |
| 4 |
Gilead Sciences
GILD
|
$5.26M |
| 5 |
TSMC
TSM
|
$3.61M |
Sector Composition
| 1 | Technology | 36.93% |
| 2 | Healthcare | 24.36% |
| 3 | Consumer Discretionary | 11.82% |
| 4 | Communication Services | 11.17% |
| 5 | Consumer Staples | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Agios Pharmaceuticals
AGIO
$2.09B
| $337K | 0.03% |
11,493
-599
| -5% | -$17.6K |
|
277
Beam Therapeutics
BEAM
$2.11B
| $332K | 0.03% |
17,022
-772
| -4% | -$15.1K |
|
278
Dynavax Technologies
DVAX
$1.18B
| $323K | 0.03% |
24,886
-2,987
| -11% | -$38.7K |
|
279
MongoDB
MDB
$26.4B
| $323K | 0.03% |
1,839
+637
| +53% | +$112K |
|
280
Arrowhead Research
ARWR
$4.02B
| $322K | 0.03% |
25,293
-1,092
| -4% | -$13.9K |
|
281
Janux Therapeutics
JANX
$1.44B
| $320K | 0.03% |
11,855
+727
| +7% | +$19.6K |
|
282
Travere Therapeutics
TVTX
$1.93B
| $319K | 0.03% |
17,800
-406
| -2% | -$7.28K |
|
283
BioCryst Pharmaceuticals
BCRX
$1.74B
| $314K | 0.03% |
41,914
-2,006
| -5% | -$15K |
|
284
Vera Therapeutics
VERA
$1.54B
| $307K | 0.03% |
12,787
-640
| -5% | -$15.4K |
|
285
MannKind Corp
MNKD
$1.7B
| $306K | 0.03% |
60,895
+2,420
| +4% | +$12.2K |
|
286
ANI Pharmaceuticals
ANIP
$2.07B
| $292K | 0.03% |
4,365
-92
| -2% | -$6.16K |
|
287
Zeekr
ZK
$7.43B
| $289K | 0.03% |
12,000
| – | – |
|
288
IDEAYA Biosciences
IDYA
$2.38B
| $288K | 0.03% |
17,558
-769
| -4% | -$12.6K |
|
289
Amphastar Pharmaceuticals
AMPH
$1.37B
| $280K | 0.03% |
9,644
-551
| -5% | -$16K |
|
290
Invesco QQQ Trust
QQQ
$368B
| $277K | 0.03% |
590
+79
| +15% | +$37.1K |
|
|
CNTA
291
Centessa Pharmaceuticals
CNTA
$2.11B
| $263K | 0.02% |
18,311
-598
| -3% | -$8.6K |
|
292
Inspire Medical Systems
INSP
$2.56B
| $251K | 0.02% |
1,574
| – | – |
|
293
ARS Pharmaceuticals
SPRY
$995M
| $245K | 0.02% |
19,494
-1,113
| -5% | -$14K |
|
294
SPDR S&P 500 ETF Trust
SPY
$660B
| $239K | 0.02% |
426
-144
| -25% | -$80.8K |
|
295
Dyne Therapeutics
DYN
$2.02B
| $237K | 0.02% |
22,690
+1,115
| +5% | +$11.7K |
|
296
Indivior
INDV
$3.12B
| $237K | 0.02% |
24,900
-4,006
| -14% | -$38.2K |
|
297
Immunocore
IMCR
$1.87B
| $236K | 0.02% |
7,947
-446
| -5% | -$13.2K |
|
298
Ardelyx
ARDX
$1.57B
| $235K | 0.02% |
47,810
-2,412
| -5% | -$11.8K |
|
299
Hilton Worldwide
HLT
$64B
| $232K | 0.02% |
1,021
-6,614
| -87% | -$1.51M |
|
300
Ocular Therapeutix
OCUL
$2.37B
| $231K | 0.02% |
31,535
-1,801
| -5% | -$13.2K |
|